Page last updated: 2024-08-23

paclitaxel and Esophageal Dysmotility

paclitaxel has been researched along with Esophageal Dysmotility in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DiCaudo, DJ; Farhey, Y; Griffing, WL; Martorano, LM; Trotter, SC; Winkelmann, JC; Winkelmann, RR; Yiannias, JA1

Reviews

1 review(s) available for paclitaxel and Esophageal Dysmotility

ArticleYear
Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis.
    International journal of dermatology, 2016, Volume: 55, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Esophageal Motility Disorders; Female; Humans; Immunohistochemistry; Middle Aged; Myositis; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prognosis; Raynaud Disease; Risk Assessment; Scleroderma, Systemic; Treatment Outcome

2016